Xiao-Tang Kong

Suggest Changes
Learn More
PURPOSE To assess the safety and efficacy of upfront treatment using bortezomib combined with standard radiation therapy (RT) and temozolomide (TMZ), followed by adjuvant bortezomib and TMZ for ≤24(More)
  • 1